Lack of modifying effects of an estrogenic compound atrazine on 7,12-dimethylbenz(a)anthracene-induced ovarian carcinogenesis in rats

Cancer Letters

Volumn 210, Issue 2, 2004, Pages 129-137

  Tanaka, Takuji ^a   Kohno, Hiroyuki ^a   Suzuki, Rikako ^a   Sugie, Shigeyuki ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

7,12 dimethylbenz(a)anthracene; Atrazine; Endocrine disrupting chemicals; Hormone receptors; Ovarian carcinogenesis; Rats

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; ATRAZINE; CARCINOGEN; CYCLINE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; NONHUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ADMINISTRATION, ORAL; ANIMALS; ATRAZINE; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DRUG INTERACTIONS; ENDOCRINE SYSTEM; FEMALE; HERBICIDES; NEOPLASMS, EXPERIMENTAL; OVARIAN NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN;

EID: 2942585124     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.01.025     Document Type: Article

References (43)

1. Tsuda H., Naito A., Kim C.K., Fukamachi K., Nomoto H., Moore M.A. Carcinogenesis and its modification by environmental endocrine disruptors: in vivo experimental and epidemiological findings. Jpn. J. Clin. Oncol. 33:2003;259-270
2. Daston G.P., Cook J.C., Kavlock R.J. Uncertainties for endocrine disrupters: our view on progress. Toxicol. Sci. 74:2003;245-252
3. Damstra T. Endocrine disrupters: the need for a refocused vision. Toxicol. Sci. 74:2003;231-232
4. Cooper R.L., Stoker T.E., Goldman J.M., Parrish M.B., Tyrey L. Effect of atrazine on ovarian function in the rat. Reprod. Toxicol. 10:1996;257-264
5. Plesmicar A., Druzina B., Kovac V., Karalj B. Environment and breast cancer-the role of xenooestrogens in breast cancer carcinogenesis. Radiol. Oncol. 36:2002;63-72
6. Roy D., Colerangle J.B., Singh K.P. Is exposure to environmental or industrial endocrine disrupting estrogen-like chemicals able to cause genomic instability? Front. Biosci. 3:1998;d913-d921
7. Birnbaum L.S., Fenton S.E. Cancer and developmental exposure to endocrine disruptors. Environ. Health Perspect. 111:2003;389-394
8. Roy D., Palangat M., Chen C.W., Thomas R.D., Colerangle J., Atkinson A., Yan Z.J. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. Toxicol. Environ. Health. 50:1997;1-29
9. Li J.J., Li S.A. Natural and anthropogenic environmental oestrogens: the scientific basis for risk assessment. Bresat cancer: evidence for xeno-oestrogen involvement in altering its incidence and risk. Pure Appl. Chem. 70:1998;1713-1723
10. Safe S., Wargovich M.J., Lamartiniere C.A., Mukhtar H. Symposium on mechanisms of action of naturally occurring anticarcinogens. Toxicol. Sci. 52:1999;1-8
11. Reiter L.W., DeRosa C., Kavlock R.J., Lucier G., Mac M.J., Melillo J., et al. The U.S. federal framework for research on endocrine disruptors and an analysis of research programs supported during fiscal year 1996. Environ. Health Perspect. 106:1998;105-113
12. Son H.-Y., Nishikawa A., Ikeda T., Nakamura H., Miyauchi M., Imazawa T., et al. Lack of modifying effects of environmental estrogenic compounds on the development of thyroid proliferative lesions in male rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn. J. Cancer Res. 91:2000;899-905
13. Son H.-Y., Nishikawa A., Ikeda T., Furukawa F., Hirose M. Lack of modification by environmental estrogenic compounds of thyroid carcinogenesis in ovariectomized rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn. J. Cancer Res. 91:2000;966-972
14. Tanaka T., Kohno H., Tanino M., Yanaida Y. Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7, 12-dimethylbenz[a] anthracene-induced ovarian carcinogenesis in rats. Ecotoxicol. Environ. Saf. 52:2002;38-45
15. Kohno H., Tsukio Y., Yanaida Y., Tanino M., Tanaka T. Lack of modifying effects of 4-n-octylphenol on 3, 2′-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis in rats. Ecotoxicol. Environ. Saf. 51:2002;210-215
16. Bisson M., Hontela A. Cytotoxic and endocrine-disrupting potential of atrazine, diazinon, endosulfan, and mancozeb in adrenocortical steroidogenic cells of rainbow trout exposed in vitro. Toxicol. Appl. Pharmacol. 180:2002;110-117
17. Loosli R. Epidemiology of atrazine. Rev. Environ. Contam. Toxicol. 143:1995;47-57
18. Stevens J.T., Breckenridge C.B., Wetzel L.T., Gillis J.H., Luempert L.G., Eldridge J.C. Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides. Toxicol. Environ. Health. 43:1994;139-153
19. Wetzel L.T., Luempert L.G., Breckenridge C.B., Tisdel M.O., Stevens J.T., Thakur A.K., et al. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats. J. Toxicol. Environ. Health. 43:1994;169-182
20. Eldridge J.C., Wetzel L.T., Stevens J.T., Simpkins J.W. The mammary tumor response in triazine-treated female rats: a threshold-mediated interaction with strain and species-specific reproductive senescence. Steroids. 64:1999;672-678
21. Goldman L.R. Simazine and Cyanazine: notice of initiation of special review. Federal register. 1994;60412-60443
22. Goldsmith D.F. Linking environmental cancer with occupational epidemiology research: the role of the International agency for research on cancer (IARC). J. Environ. Pathol. Toxicol. Oncol. 19:2000;171-175
23. IARC. Monographs on the ecaluation of the carcinogenic risk of chemicals to humans. Monographs on the Ecaluation of the Carcinogenic Risk of Chemicals to Humans. 1991;IARC, Lyon
24. Pinter A., Torok G., Borzsonyi M., Surjan A., Csik M., Kelecsenyi Z., Kocsis Z. Long-term carcinogenicity bioassay of the herbicide atrazine in F344 rats. Neoplasma. 37:1990;533-544
25. Kligerman A.D., Doerr C.L., Tennant A.H., Zucker R.M. Cytogenetic studies of three triazine herbicides. I. In vitro studies. Mutat. Res. 465:2000;53-59
26. Kligerman A.D., Doerr C.L., Tennant A.H., Peng B. Cytogenetic studies of three triazine herbicides. II. In vivo micronucleus studies in mouse bone marrow. Mutat. Res. 47:2000;107-112
27. Nicosia S.V., Bai W., Cheng J.Q., Coppola D., Kruk P.A. Oncogenic pathways implicated in ovarian epithelial cancer. Hematol. Oncol. Clin North Am. 17:2003;927-943
28. Motta P.M. Morphodynamic changes of the mammalian ovary as revealed by scanning electron microscopy. Folia Morphol. (Praha). 28:1980;79-81
29. Bai W., Oliveros-Saunders B., Wang Q., Acevedo-Duncan M.E., Nicosia S.V. Estogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev. Biol. Anim. 36:2000;657-666
30. Laws S.C., Ferrell J.M., Stoker T.E., Schmid J., Cooper R.L. The effects of atrazine on female wistar rats: an evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol. Sci. 58:2000;366-376
31. Cooper R.L., Stoker T.E., Tyrey L., Goldman J.M., McElroy W.K. Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol. Sci. 53:2000;297-307
32. Lau K.-M., Mok S.C., Ho S.-M. Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells, Proc. Natl. Acad. Sci. USA. 96:1999;5722-5727
33. Doerge D.R., Sheehan D.M. Goitrogenic and estrogenic activity of soy isoflavones. Environ. Health Perspect. 110:(Suppl.3):2002;349-353
34. Son H.Y., Nishikawa A., Okazaki K., Lee K.Y., Imazawa T., Hirose M. Lack of modifying effects of atrazine and/or tamoxifen on thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Food Chem. Toxicol. 41:2003;1811-1816
35. Bakke J.E., Larson J.D., Price C.E. Metabolism of atrazine and 2-hydroxyatrazine by the rat. J. Agric. Food Chem. 20:1972;602-607
36. 14C]-atrazine following oral administration to male Fischer 344 rats. Toxicology. 61:1990;27-40
37. Barbicri F., Catenacci G., Feriolo A., Cottica D., Maroni M. Atrazine exposure and metabolism in occupational exposed workers. Toxicol. Lett. Suppl. 1992;83
38. Adams N.H., Levi P.E., Hodgson E. In vivo studies of the metabolism of atrazine, simazine, and terbutryn in several vertebrate species. J. Agric. Food Chem. 38:1990;1411-1411
39. Hoar Zahm S., Weisenburger D.D., Cantor K.P., Holmes F.F., Blair A. Role of the herbicide atrazine in the development of non-Hodgkin's lymphoma. Scand. J. Work Environ Health. 19:1993;108-114
40. Donna A., Crosignani P., Robutti F., Betta P., Bocca R., Mariani N., et al. Triazine herbicides and ovarian epithelial neoplasms. Scand. J. Work Environ. Health. 15:1989;47-53
41. Hopenhayn-Rich C., Stump M.L., Browning S.R. Regional assessment of atrazine exposure and incidence of breast and ovarian cancers in Kentucky. Arch. Environ. Contam. Toxicol. 42:2002;127-136
42. Shaw P.A., Rittenberg P.V., Brown T.J. Activation of androgen receptor-associated protein 70 (ARA70) mRNA expression in ovarian cancer. Gynecol. Oncol. 80:2001;132-138
43. Ahonen M.H., Zhuang Y.-H., Aine R., Ylikomi T., Tuohimaa P. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int. J. Cancer. 86:2000;40-46